An update on the multimodality of localized rectal cancer

被引：4

作者：

Artac, Mehmet ^{[1
]}

Korkmaz, Levent ^{[1
]}

El-Rayes, Bassel ^{[2
]}

Philip, Philip A. ^{[3
]}

机构：

[1] Necmettin Erbakan Univ, Meram Med Fac, Dept Med Oncol, Konya, Turkey

[2] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA

[3] Karmanos Canc Ctr, Dept Gastrointestinal Oncol, Detroit, MI USA

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2016年 / 108卷

关键词：

Rectal cancer; Locally advanced; Neo-adjuvant; Surgery; Chemo-radiotherapy; PHASE-III TRIAL; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; WILD-TYPE KRAS; PREOPERATIVE RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; NEOADJUVANT CHEMORADIOTHERAPY;

D O I：

10.1016/j.critrevonc.2016.10.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

New strategies have reduced the local recurrence (LR) rate and extended the duration of overall survival (OS) in patients with localized rectal cancer (RC) in recent decades. The mainstay of curative treatment remains radical surgery; however, downsizing the tumor by neo-adjuvant chemo-radiotherapy and adjuvant cytotoxic therapy for systemic disease has shown significant additional benefit. The standardization of total mesorectal excision (TME), radiation treatment (RT) dose and fractionation, and optimal timing and sequencing of treatment modalities with the use of prolonged administration of fluoropyrimidine concurrent with RT have significantly decreased the rates of LR in locally advanced rectal cancer (LARC) patients. This review focuses on the optimization of multi-modality therapies in patients with localized RC. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

引用

页码：23 / 32

页数：10

共 94 条

[41] Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: A pooled analysis [J].

Gunderson, LL ;

Sargent, DJ ;

Tepper, JE ;

O'Connell, MJ ;

Allmer, C ;

Smalley, SR ;

Martenson, JA ;

Haller, DG ;

Mayer, RJ ;

Rich, TA ;

Ajani, JA ;

MacDonald, JS ;

Goldberg, RM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02) :386-396

[42] Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results [J].

Habr-Gama, A ;

Perez, RO ;

Nadalin, W ;

Sabbaga, J ;

Ribeiro, U ;

Sousa, AHSE ;

Campos, FG ;

Kiss, DR ;

Gama-Rodrigues, J .

ANNALS OF SURGERY, 2004, 240 (04) :711-717

[43] Locally recurrent rectal cancer in Norway [J].

Hansen, M. H. ;

Balteskard, L. ;

Dorum, L. M. ;

Eriksen, M. T. ;

Voenn, B. .

BRITISH JOURNAL OF SURGERY, 2009, 96 (10) :1176-1182

[44] A placebo-controlled trial of aprepitant for cough in lung cancer. [J].

Harle, Amelie Sylvia Mary ;

Smith, Jaclyn A. ;

Molassiotis, Alex ;

Lofthouse, Kimberley ;

Dockry, Rachel ;

Russell, Philip ;

Burns, Katy ;

Blackhall, Fiona Helen .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)

[45]

HEALD RJ, 1979, BRIT J HOSP MED, V22, P277

[46] Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07 [J].

Helbling, D. ;

Bodoky, G. ;

Gautschi, O. ;

Sun, H. ;

Bosman, F. ;

Gloor, B. ;

Burkhard, R. ;

Winterhalder, R. ;

Madlung, A. ;

Rauch, D. ;

Saletti, P. ;

Widmer, L. ;

Borner, M. ;

Baertschi, D. ;

Yan, P. ;

Benhattar, J. ;

Leibundgut, E. O. ;

Bougel, S. ;

Koeberle, D. .

ANNALS OF ONCOLOGY, 2013, 24 (03) :718-725

[47] Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial [J].

Hofheinz, Ralf-Dieter ;

Wenz, Frederik ;

Post, Stefan ;

Matzdorff, Axel ;

Laechelt, Stephan ;

Hartmann, Joerg T. ;

Mueller, Lothar ;

Link, Hartmut ;

Moehler, Markus ;

Kettner, Erika ;

Fritz, Elisabeth ;

Hieber, Udo ;

Lindemann, Hans Walter ;

Grunewald, Martina ;

Kremers, Stephan ;

Constantin, Christian ;

Hipp, Matthias ;

Hartung, Gernot ;

Gencer, Deniz ;

Kienle, Peter ;

Burkholder, Iris ;

Hochhaus, Andreas .

LANCET ONCOLOGY, 2012, 13 (06) :579-588

[48]

Hong Theodore S, 2007, Gastrointest Cancer Res, V1, P49

[49] PREOPERATIVE RADIOTHERAPY IN OPERABLE RECTAL-CANCER [J].

HORN, A ;

HALVORSEN, JF ;

DAHL, O .

DISEASES OF THE COLON & RECTUM, 1990, 33 (10) :823-828

[50] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

← 1 2 3 4 5 6 7 8 9 10 →